Jove
Visualize
联系我们

相关概念视频

Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

4.2K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.2K
iPS Cell Differentiation01:22

iPS Cell Differentiation

2.8K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.8K
Stem Cell Culture01:17

Stem Cell Culture

5.4K
Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
5.4K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

GPSM1 restricts CD73<sup>+</sup>CD103<sup>+</sup> T<sub>reg</sub> cells in adipose tissue, critical for promoting obesity-related metabolic deterioration.

Nature communications·2026
Same author

Hypertensive heart disease attributable to high BMI: global trends, gender disparities, and SDI-based inequalities (1990-2021).

Journal of human hypertension·2026
Same author

Cardiac CT Angiography in Diagnosing Patent Foramen Ovale: A Study on Patients with Suspected Patent Foramen Ovale-Associated Stroke.

Journal of cardiovascular development and disease·2026
Same author

Dual Enhancement of Air Stability and Na<sup>+</sup> Diffusion Kinetics in O3-Type High-Entropy Cathode Materials via Na Vacancy Engineering.

Langmuir : the ACS journal of surfaces and colloids·2026
Same author

Transcriptomic analysis under the stress of insecticides and the functional role of three genes related to host finding behavior of Scleroderma sichuanensis.

Comparative biochemistry and physiology. Part D, Genomics & proteomics·2026
Same author

Novel compound heterozygous <i>ALPK3</i> mutations (c.4234C>T and c.3491G>A), causing hypertrophic cardiomyopathy treated with the liwen procedure: case report.

Frontiers in cardiovascular medicine·2025
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关实验视频

Updated: Sep 17, 2025

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
07:50

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

4.7K

在缺血性心力衰竭中使用干细胞治疗.

Quanchi Guo1, Yang Hua2

  • 1China Medical University, Shenyang, 110000, China. 1652700861@qq.com.

American journal of cardiovascular drugs : drugs, devices, and other interventions
|June 27, 2025
PubMed
概括

干细胞疗法对缺血性心力衰竭有前途,但面临着挑战. 需要进一步的研究来提高干细胞的活力,克服免疫排斥,并降低成功临床转换的成本.

科学领域:

  • 再生医学是一种再生医学.
  • 心血管研究研究心血管研究
  • 干细胞生物学 干细胞生物学

背景情况:

  • 缺血性心力衰竭仍然是全球死亡的主要原因.
  • 干细胞疗法为心脏修复提供了一个有前途的再生方法.
  • 目前对干细胞治疗心力衰竭的临床翻译受到几个挑战的限制.

研究的目的:

  • 审查干细胞治疗的应用,机制和缺血性心力衰竭的临床试验.
  • 讨论提高干细胞活力和保留的策略.
  • 确定心力衰竭中干细胞治疗的挑战和未来前景.

主要方法:

  • 关于干细胞治疗缺血性心力衰竭的临床前和临床研究的综合文献综述.
  • 干细胞机制的分析,包括再肌肉化和膜效应.
  • 评估用于干细胞移植的输送方法和生物材料.

主要成果:

  • 干细胞治疗在临床前和临床环境中表现出令人鼓舞的结果.
  • 关键的机制包括膜效应,肌肉复原和自身膜信号.
  • 输送途径和生物材料,如水凝和心脏贴片可以改善细胞保留.

结论:

更多相关视频

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment
08:24

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Published on: May 25, 2020

7.0K
Ultrasound-Guided Induced Pluripotent Stem Cell-Derived Cardiomyocyte Implantation in Myocardial Infarcted Mice
08:03

Ultrasound-Guided Induced Pluripotent Stem Cell-Derived Cardiomyocyte Implantation in Myocardial Infarcted Mice

Published on: March 30, 2022

1.7K

相关实验视频

Last Updated: Sep 17, 2025

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
07:50

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model

Published on: September 3, 2020

4.7K
Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment
08:24

Establishing a Swine Model of Post-myocardial Infarction Heart Failure for Stem Cell Treatment

Published on: May 25, 2020

7.0K
Ultrasound-Guided Induced Pluripotent Stem Cell-Derived Cardiomyocyte Implantation in Myocardial Infarcted Mice
08:03

Ultrasound-Guided Induced Pluripotent Stem Cell-Derived Cardiomyocyte Implantation in Myocardial Infarcted Mice

Published on: March 30, 2022

1.7K
  • 干细胞治疗具有治疗缺血性心力衰竭的巨大潜力.
  • 克服免疫排斥,缺氧和成本等挑战对于临床成功至关重要.
  • 持续的研究对于优化干细胞治疗和建立明确的临床应用至关重要.